Lilly, Aktis sign radiopharmaceuticals pact - Chemical

May 23, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

CouponFollow Extension

$60
OFF

Lilly, Aktis Sign Radiopharmaceuticals Pact - Chemical

4 weeks from now

May 23, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

acs.org

$60
OFF

Lilly, Aktis Sign Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

May 27, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

acs.org

$60
OFF

Lilly Partners With Aktis, Deepening Radiopharma Investment

4 weeks from now

May 21, 2024 · Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will pay the startup $60 million …

biopharmadive.com

$1
OFF

Lilly Collaborates With Aktis To Strengthen Radiopharma Portfolio

4 weeks from now

May 21, 2024 · Eli Lilly previously inked a $1.4bn deal to acquire radiopharmaceutical company POINT Biopharma in October 2023. Credit: Michael Vi via Shutterstock. Eli Lilly is once again …

pharmaceutical-technology.com

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$1
OFF

Aktis To Collaborate With Eli Lilly On Cancer Therapies

4 weeks from now

May 21, 2024 · Aktis Oncology said on Tuesday it will collaborate with Eli Lilly to develop cancer therapies, making it eligible for milestone payments of up to $1.1 billion and royalties on sales.

reuters.com

$140
OFF

Lilly Builds In Radiopharma With $140m Radionetics Deal

4 weeks from now

4 days ago · Meanwhile, in May, Lilly paid $60 million upfront to use Aktis Oncology's technology to generate radiopharma candidates for solid tumours in a deal that could be worth up to $1.1 …

pharmaphorum.com

$140
OFF

Lilly Signs $140M Radiopharma Partnership With Radionectics

4 weeks from now

Jul 1, 2024 · Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal The biotech hauled in a $52.5 million series A at the start of this year, bringing the total the company had …

fiercebiotech.com

$140
OFF

Lilly Signs Another Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

Jul 15, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

$140
OFF

Lilly Enters $140 Million Radiopharmaceutical Pact

4 weeks from now

Jul 11, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

FAQs about Lilly, Aktis sign radiopharmaceuticals pact - Chemical Coupon?

Is Eli Lilly partnering with aktis oncology?

Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will pay the startup $60 million upfront. Per terms announced Tuesday, Aktis could receive as much as $1.1 billion more from Lilly if certain milestones are met. Lilly is also making an equity investment in Aktis. ...

How much will Lilly pay for aktis oncology?

Meanwhile, in May, Lilly paid $60 million upfront to use Aktis Oncology's technology to generate radiopharma candidates for solid tumours in a deal that could be worth up to $1.1 billion. ...

How much money will aktis receive from Lilly?

Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. In addition, Aktis will be eligible to receive up to an additional $1.1 billion in potential preclinical, clinical, regulatory and commercial milestones, as well as tiered royalties. ...

What is the difference between Akt & Lilly?

Aktis responsible for program discovery through initial human imaging studies; Lilly responsible for worldwide clinical development and commercialization from Phase 1 onward ...

Will Lilly acquire aktis pharmaceuticals?

Under the terms of the agreement, Lilly will gain worldwide rights to develop targets for radiopharmaceuticals discovered by Aktis. However, the deal does not include Aktis’ current pipeline, which consists of seven programmes. ...

Will aktis partner with Lilly?

"We are pleased to partner with Lilly in efforts to increase the number of patients that can derive meaningful clinical benefit from targeted radiopharmaceuticals." Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. ...